Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations
about
MSMB gene rs10993994 polymorphism increases the risk of prostate cancer.Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT studyIdentification of candidate susceptibility genes for colorectal cancer through eQTL analysis.MALDI-target integrated platform for affinity-captured protein digestionThe use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers.The rs10993994 in the proximal MSMB promoter region is a functional polymorphism in Asian Indian subjects.Development and validation of a UHPLC-UV method for the determination of a prostate secretory protein 94-derived synthetic peptide (PCK3145) in human plasma and assessment of its stability in human plasma.Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community CohortThe genetic epidemiology of prostate cancer and its clinical implications.Vasectomy and Prostate Cancer Risk in the European Prospective Investigation Into Cancer and Nutrition (EPIC).Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel.A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project.Parafilm-assisted microdissection: a sampling method for mass spectrometry-based identification of differentially expressed prostate cancer protein biomarkers
P2860
Q33709757-C71E9C46-36DC-4D73-8B02-CB82D10A9E6AQ33927384-C7552898-3D48-4C40-BE5D-84E9F05799B8Q34096808-A2D04258-C9B7-4212-8395-E7BD8C968F4AQ35072160-740F59E6-CF22-4C72-9411-A36FFF98AED2Q35891644-5CB97FC6-302B-4E7C-9C4B-D151000B4945Q35892333-953EFDF4-91E4-4E85-9715-9648BFCE703AQ35927899-4537B539-3354-407C-A72A-1C8BDB42DB0CQ35944835-515A026C-F1E6-4071-9F34-E0C95239D2B2Q36275998-8591F719-78F0-47F0-8E3D-68D29F98C125Q38168060-6030E12A-9C82-4017-A387-5E8564DE983FQ38856010-075F2B25-2964-4190-BCE3-415A32B3B42EQ40417671-8EE64D01-F53A-42F2-AA46-BAA1BB9DBE0DQ48520586-F775652A-C70A-4CD7-AF44-E1C0FF55E310Q49787829-3D88B887-E1A4-4AB5-BEE6-D417B771FE11Q58356220-D776BC82-8BE3-425F-B971-79DCC5CE9CBB
P2860
Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Levels of beta-microseminoprot ...... cancer in multiple populations
@ast
Levels of beta-microseminoprot ...... cancer in multiple populations
@en
type
label
Levels of beta-microseminoprot ...... cancer in multiple populations
@ast
Levels of beta-microseminoprot ...... cancer in multiple populations
@en
prefLabel
Levels of beta-microseminoprot ...... cancer in multiple populations
@ast
Levels of beta-microseminoprot ...... cancer in multiple populations
@en
P2093
P2860
P50
P356
P1476
Levels of beta-microseminoprot ...... cancer in multiple populations
@en
P2093
Camilla Valtonen-André
Daniel O Stram
Katharina Braun
Kevin M Waters
Kim Pettersson
Laurence N Kolonel
Lynne R Wilkens
Mari Peltola
P2860
P304
P356
10.1093/JNCI/DJS486
P407
P577
2012-12-03T00:00:00Z